Viewing Study NCT01586195


Ignite Creation Date: 2025-12-24 @ 2:15 PM
Ignite Modification Date: 2025-12-25 @ 12:53 PM
Study NCT ID: NCT01586195
Status: TERMINATED
Last Update Posted: 2017-05-25
First Post: 2012-04-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600E
Sponsor: Genentech, Inc.
Organization: